Jianhua Yu
Immunology and Microbiology · The Ohio State University
Publications
488
Citations
24,054
Est. group size
~2
Recurring co-author estimate
Active years
31
Publishing since 1996
Jianhua Yu's research focuses on immune cells, especially natural killer (NK) cells and T cells, and how they can be engineered or manipulated to fight cancer, including through CAR-based cell therapies. Work also explores molecular mechanisms like RNA methylation (m6A) that regulate immune cell activation, and how these processes affect responses to cancer treatment. Prospective students would likely engage with topics spanning basic immune cell biology, cancer immunotherapy engineering, and RNA biology.
Publication output has grown substantially over the last decade, rising from under 20 papers per year around 2017-2020 to a peak of 65 in 2024, though with year-to-year fluctuation.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Supplementary Figure S7 from mTOR Signaling Promotes Rapid m<sup>6</sup>A mRNA Methylation to Regulate NK-Cell Activation and Effector Functions
2026
- Supplementary Figure S3 from mTOR Signaling Promotes Rapid m<sup>6</sup>A mRNA Methylation to Regulate NK-Cell Activation and Effector Functions
2026
- Supplementary Figure S1 from mTOR Signaling Promotes Rapid m<sup>6</sup>A mRNA Methylation to Regulate NK-Cell Activation and Effector Functions
2026
- Supplementary Figure S6 from mTOR Signaling Promotes Rapid m<sup>6</sup>A mRNA Methylation to Regulate NK-Cell Activation and Effector Functions
2026
- Supplementary Figure S2 from mTOR Signaling Promotes Rapid m<sup>6</sup>A mRNA Methylation to Regulate NK-Cell Activation and Effector Functions
2026
- Supplementary Figure S4 from mTOR Signaling Promotes Rapid m<sup>6</sup>A mRNA Methylation to Regulate NK-Cell Activation and Effector Functions
2026
- Supplementary Figure S5 from mTOR Signaling Promotes Rapid m<sup>6</sup>A mRNA Methylation to Regulate NK-Cell Activation and Effector Functions
2026
- Research on Fluorescent Penetrant Inspection and Plasma Modification of Surface Microcracks in Silicone Rubber Composite Insulators
ChemistrySelect · 2026
- Emerging combined CAR-NK cell therapies in cancer treatment: Finding a dancing partner
Molecular Therapy · 2025
- Natural killer cell–based immunotherapy for cancer
The Journal of Immunology · 2025
- The RNA-stability-independent role of the RNA m6A reader YTHDF2 in promoting protein translation to confer tumor chemotherapy resistance
Molecular Cell · 2025
- Off-the-shelf invariant NKT cells expressing anti-PSCA CAR and IL-15 promote pancreatic cancer regression in mice
Journal of Clinical Investigation · 2025
- Loss of YTHDF2 enhances Th9 programming and CAR-Th9 cell antitumor efficacy
Nature Immunology · 2025
- Comparative efficacy and safety of PSCA CAR-engineered Vδ1 γδ T cells for immunotherapy of pancreatic cancer
Journal for ImmunoTherapy of Cancer · 2025
- NKp46 enhances type 1 innate lymphoid cell proliferation and function and anti-acute myeloid leukemia activity
Nature Communications · 2025
- Nature Communications×11
- Cancer Research×10
- Blood×10
- Frontiers in Immunology×9
- The Journal of Immunology×7
- Hsiaoyin Mao
Immunology and Microbiology · The Ohio State University
- Kenneth J. Oestreich
Immunology and Microbiology · The Ohio State University
- Dean A. Lee
Immunology and Microbiology · The Ohio State University
- Randy R. Brutkiewicz
Immunology and Microbiology · Indiana University
- Jilu Zhang
Immunology and Microbiology · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile